Welcome and Introduction (ID 4759)
The Journey Towards Improving Survival Outcomes in Patients With HR+/HER2– ABC (ID 4760)
Expanding Horizons: Overall Survival and Quality of Life Benefit of CDK4/6 Inhibitors in Patients with HR+/HER2– ABC (ID 4761)
Harnessing the PI3K pathway to improve survival in patients with PIK3CA-mutated HR+/HER2– ABC (ID 4762)
Understanding the Patient Perspective - Live Moderated Panel Discussion (ID 4763)
